Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial
- 1 February 2010
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 375 (9715), 664-672
- https://doi.org/10.1016/s0140-6736(09)61962-0
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Aquatic Invertebrates as Unlikely Vectors of Buruli Ulcer DiseaseEmerging Infectious Diseases, 2008
- Mycobacterium ulceransin Mosquitoes Captured during Outbreak of Buruli Ulcer, Southeastern AustraliaEmerging Infectious Diseases, 2007
- Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer ( Mycobacterium ulcerans Disease)Antimicrobial Agents and Chemotherapy, 2007
- Risk Factors for Buruli Ulcer, BeninEmerging Infectious Diseases, 2006
- Mycobacterium ulcerans infection: control, diagnosis, and treatmentThe Lancet Infectious Diseases, 2006
- Contiguous spread of Mycobacterium ulcerans in Buruli ulcer lesions analysed by histopathology and real‐time PCR quantification of mycobacterial DNAThe Journal of Pathology, 2005
- Risk Factors for Buruli Ulcer Disease (Mycobacterium ulcerans Infection): Results from a Case-Control Study in GhanaClinical Infectious Diseases, 2005
- Analysis of an IS 2404 -Based Nested PCR for Diagnosis of Buruli Ulcer Disease in Regions of Ghana Where the Disease Is EndemicJournal of Clinical Microbiology, 2003
- A CONTROLLED TRIAL OF THE TREATMENT OF MYCOBACTERIUM ULCERANS INFECTION WITH CLOFAZIMINEThe Lancet, 1973